Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pituitary tumor
Trial Type:  Treatment
Results 1-5 of 5 for your search:
Start Over
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CSOM230B2412, NCI-2017-01247, NCT01794793
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: CLCI699C2301, NCI-2017-00022, 2013-004766-34, NCT02180217
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
OTL38 in Imaging Patients with Suspected Pituitary Adenoma Undergoing Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC 18315, NCI-2015-01600, 822782, NCT02769533
Mifepristone in Treating Patients With Cancer
Status: Enrolling by invitation
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: INST 0817, NCI-2011-02682, NCT00832871
Start Over